ArticleBioPsychoSocial medicine2026
Depressive and anxiety symptoms in COPD: associations with diffusion impairment and echocardiographic pulmonary hemodynamic burden.
Article in BioPsychoSocial medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPsychological distress is common yet often underrecognized in chronic obstructive pulmonary disease (COPD). Physiological correlates beyond spirometry may support biopsychosocial assessment in routine care, but their relation to depressive and anxiety symptoms remain insufficiently characterized.
methodsIn this single-center cross-sectional study, 56 clinically stable Japanese COPD outpatients (mean age 73 years; 87.5% men) completed the Self-Rating Depression Scale (SDS) and the State-Trait Anxiety Inventory (STAI). Clinical assessments included spirometry, %DLCO/VA, echocardiographic tricuspid regurgitation pressure gradient (TRPG), body mass index (BMI), and blood biomarkers. Associations were examined using Spearman's rank correlation and multivariable linear regression adjusted for age, sex, and BMI; Model 1 included %DLCO/VA and Model 2 included TRPG. Bootstrap resampling was used to assess the stability of key regression coefficients.
resultsDepressive symptoms (SDS ≥ 40) were present in 46.5% of the patients (severe 5.4%), and elevated state anxiety in 41.1% (severe 12.5%). SDS scores were correlated with lower %DLCO/VA, higher TRPG, and lower BMI. STAI-state scores were correlated with higher TRPG. In adjusted analyses, lower %DLCO/VA was independently associated with higher SDS scores, whereas higher TRPG was independently associated with higher SDS and STAI-state scores. %FEV1 was not associated with SDS or STAI scores.
conclusionsIn this Japanese outpatient COPD cohort, depressive and anxiety symptoms were common. Elevated TRPG showed a more consistent association with psychological symptoms in bootstrap analyses, whereas lower %DLCO/VA was associated with depressive symptoms but showed less stable bootstrap support than the TRPG findings. These findings support an integrated biopsychosocial assessment approach to routine COPD care, incorporating physiological information beyond spirometric airflow measures.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.